The annual European Society for Medical Oncology (ESMO) congress is one of the most important events in the annual calendar for cancer drug developers, oncologists and patients. This year’s meeting is shaping up to be no different – read our preview here.
Join FirstWord Pharma PLUS editors Michael Flanagan, Virginia Li and Simon King for a 30-minute conversation on Wednesday 22 September (3pm GMT / 10am EST), where they will discuss their five key takeaways from this year’s meeting and answer your questions.
Register for free here
To read more ViewPoints articles, click here.